{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T13:13:58Z","timestamp":1768569238097,"version":"3.49.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"German Bundesamt f\u00fcr Wehrtechnik und Beschaffung","award":["U2.3 \u2013 E\/UR3G\/5G031\/5A802"],"award-info":[{"award-number":["U2.3 \u2013 E\/UR3G\/5G031\/5A802"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.ejpb.2014.06.008","type":"journal-article","created":{"date-parts":[[2014,7,2]],"date-time":"2014-07-02T03:06:51Z","timestamp":1404270411000},"page":"510-517","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Freeze-drying of HI-6-loaded recombinant human serum albumin nanoparticles for improved storage stability"],"prefix":"10.1016","volume":"88","author":[{"given":"Miriam","family":"Dadparvar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvia","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sascha","family":"Wien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franz","family":"Worek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hagen","family":"von Briesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"Kreuter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2014.06.008_b0005","doi-asserted-by":"crossref","first-page":"e14213","DOI":"10.1371\/journal.pone.0014213","article-title":"Nanoparticulate transport of oximes over an in vitro blood\u2013brain barrier model","volume":"5","author":"Wagner","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ejpb.2014.06.008_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2013.09.015","article-title":"Limitations and challenges in treatment of acute chemical warfare agent poisoning","author":"Thiermann","year":"2013","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejpb.2014.06.008_b0015","series-title":"Chemical Warfare Agents: Toxicology and Treatments","first-page":"305","article-title":"Oximes","author":"Eyer","year":"2007"},{"key":"10.1016\/j.ejpb.2014.06.008_b0020","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2478\/v10136-009-0005-9","article-title":"In vitro screening of blood\u2013brain barrier penetration of clinically used acetylcholinesterase reactivators","volume":"8","author":"Karasova","year":"2010","journal-title":"J. Appl. Biomed."},{"key":"10.1016\/j.ejpb.2014.06.008_b0025","series-title":"Chemical Warfare Agents: Toxicology and Treatments","first-page":"191","article-title":"Toxicology of organophosphate nerve agents","author":"Marrs","year":"2007"},{"key":"10.1016\/j.ejpb.2014.06.008_b0030","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.toxlet.2011.06.027","article-title":"HI 6 human serum albumin nanoparticles - Development and transport over an in vitro blood\u2013brain barrier model","volume":"206","author":"Dadparvar","year":"2011","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.ejpb.2014.06.008_b0035","doi-asserted-by":"crossref","first-page":"e32568","DOI":"10.1371\/journal.pone.0032568","article-title":"Uptake mechanism of ApoE-modified nanoparticles on brain capillary endothelial cells as a blood\u2013brain barrier model","volume":"7","author":"Wagner","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejpb.2014.06.008_b0040","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/BF00290549","article-title":"Studies on the decomposition of the oxime HI 6 in aqueous solution","volume":"59","author":"Eyer","year":"1986","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.ejpb.2014.06.008_b0045","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/BF00570145","article-title":"Study on the stability of the oxime HI 6 in aqueous solution","volume":"62","author":"Eyer","year":"1988","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.ejpb.2014.06.008_b0050","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejpb.2006.01.015","article-title":"Investigation of nanocapsules stabilization by amorphous excipients during freeze-drying and storage","volume":"63","author":"Abdelwahed","year":"2006","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2014.06.008_b0055","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ijpharm.2008.07.004","article-title":"Freeze drying of human serum albumin (HSA) nanoparticles with different excipients","volume":"363","author":"Anhorn","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2014.06.008_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2009.02.002","article-title":"Physico-chemical characterisation of PLGA-nanoparticles after freeze-drying and storage","author":"Holzer","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2014.06.008_b0065","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.addr.2006.09.017","article-title":"Freeze-drying of nanoparticles: formulation, process and storage considerations","volume":"58","author":"Abdelwahed","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2014.06.008_b0070","doi-asserted-by":"crossref","first-page":"329","DOI":"10.4161\/biom.23246","article-title":"Effect of cryoprotectants on the porosity and stability of insulin-loaded PLGA nanoparticles after freeze-drying","volume":"2","author":"Fonte","year":"2012","journal-title":"Biomatter"},{"key":"10.1016\/j.ejpb.2014.06.008_b0075","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijpharm.2007.06.028","article-title":"Human serum albumin (HSA) nanoparticles: reproducibility of preparation process and kinetics of enzymatic degradation","volume":"347","author":"Langer","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2014.06.008_b0080","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0378-5173(99)00420-2","article-title":"Desolvation process and surface characteristics of HSA-nanoparticles","volume":"196","author":"Weber","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2014.06.008_b0085","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0378-5173(03)00134-0","article-title":"Optimization of the preparation process for human serum albumin (HSA) nanoparticles","volume":"257","author":"Langer","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2014.06.008_b0090","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s002040050100","article-title":"Pharmacokinetics of the oximes HI 6 and HLo 7 in dogs after i.m. injection with newly developed dry\/wet autoinjectors","volume":"68","author":"Sp\u00f6hrer","year":"1994","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.ejpb.2014.06.008_b0095","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ejpb.2013.05.019","article-title":"Recent advances and further challenges in lyophilization","volume":"85","author":"Kasper","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2014.06.008_b0100","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1023\/A:1014229001433","article-title":"Thermophysical properties of pharmaceutically compatible buffers at sub-zero temperatures: implications for freeze-drying","volume":"19","author":"Shalaev","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2014.06.008_b0105","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ijpharm.2011.04.046","article-title":"A toolbox for the upscaling of ethanolic human serum albumin (HSA) desolvation","volume":"414","author":"Wacker","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2014.06.008_b0110","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/clinchem\/37.3.398","article-title":"Determination of product shelf life and activation energy for five drugs of abuse","volume":"37","author":"Anderson","year":"1991","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ejpb.2014.06.008_b0115","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.bcp.2004.07.038","article-title":"Kinetic analysis of interactions between human acetylcholinesterase, structurally different organophosphorus compounds and oximes","volume":"68","author":"Worek","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejpb.2014.06.008_b0120","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejpb.2014.06.008_b0125","series-title":"Enzyme Inhibitors as Subtrates \u2013 Interactions of Esterases with Esters of Organophosphorus and Carbamic Acids","author":"Aldridge","year":"1972"},{"key":"10.1016\/j.ejpb.2014.06.008_b0130","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/0272-0590(86)90224-1","article-title":"Kinetic studies and structure\u2013activity relationships of bispyridinium oximes as reactivators of acetylcholinesterase inhibited by organophosphorus compounds","volume":"6","author":"Su","year":"1986","journal-title":"Fundam. Appl. Toxicol."},{"key":"10.1016\/j.ejpb.2014.06.008_b0135","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1007\/BF02980247","article-title":"Effects of sugar additives on protein stability of recombinant human serum albumin during lyophilization and storage","volume":"30","author":"Han","year":"2007","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.ejpb.2014.06.008_b0140","series-title":"Freeze-drying of Pharmaceutical and Food Products","author":"Hua","year":"2010"},{"key":"10.1016\/j.ejpb.2014.06.008_b0145","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/BF01914242","article-title":"The determination of residual moisture in several freeze-dried vaccines and a Honey Bee Venom Allergenic Extract by TG\/MS","volume":"31","author":"May","year":"1986","journal-title":"J. Therm. Anal."},{"key":"10.1016\/j.ejpb.2014.06.008_b0150","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ejpb.2006.06.002","article-title":"Impact of freezing procedure and annealing on the physico-chemical properties and the formation of mannitol hydrate in mannitol\u2013sucrose\u2013NaCl formulations","volume":"64","author":"Hawe","year":"2006","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2014.06.008_b0155","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ejpb.2013.04.010","article-title":"Controlling the physical form of mannitol in freeze-dried systems","volume":"85","author":"Mehta","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2014.06.008_b0160","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ejpb.2011.03.010","article-title":"The freezing step in lyophilization: physico-chemical fundamentals, freezing methods and consequences on process performance and quality attributes of biopharmaceuticals","volume":"78","author":"Kasper","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2014.06.008_b0165","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ejps.2006.02.003","article-title":"Physico-chemical lyophilization behavior of mannitol, human serum albumin formulations","volume":"28","author":"Hawe","year":"2006","journal-title":"Eur. J. Pharm. Sci."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641114002008?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641114002008?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T21:31:19Z","timestamp":1598045479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641114002008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0939641114002008"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2014.06.008","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Freeze-drying of HI-6-loaded recombinant human serum albumin nanoparticles for improved storage stability","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2014.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}